SSO Breast Disease Site Work Group is pleased to collaborate with the Korean Breast Cancer Society to discuss: The Management of Germline Mutations in Breast Cancer.

After this virtual tumor board, the participants will be able to: 

• Discuss management of BRCA mutation in men with regards to testing recommendations and surveillance, etc.
• Discussion on germline mutation testing and risk reduction mastectomy, especially in genes without clear breast cancer correlations and variant of unknown significance
• Compare and contrast the use of risk reducing mastectomy in USA and Korea.

Moderators - SSO

• Ko Un (Clara) Park, MD - Brigham and Women’s Hospital/ Dana-Farber Cancer Institute/ Harvard Medical School

Moderators-ESSO

• Jeong Eon Lee, MD, PhD, FACS - Samsung Medical Center, Seoul, Korea

Panelists:

• Kelly K. Hunt, MD, FSSO - MD Anderson Cancer Center
• Doreen Agnese, MD - The Ohio State University James Comprehensive Cancer Center
• Won Shik Han, MD - Seoul National University Hospital, Seoul, Korea
• Hee Jeong Kim, MD - Asan Medical Center, Seoul, Korea
• Sung Gwe Ahn, MD - Gangnam Severance Hospital, Seoul, Korea